. . . . . . "Antiangiogene Therapie in Kombination mit Temozolomid beim experimentellen MGMT-methylierten Glioblastom" . "Combining sunitinib and temozolomide in the treatment of malignant MGMT-methylated glioma enhances antitumor efficacy but promotes vascular resistance mechanisms" . . .